Npc-12Y Gel
Tuberous Sclerosis Complex
NobelpharmaPhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
13 Active assets in the Tuberous Sclerosis Complex cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Everolimus Hospices Civils de Lyon | Phase 3 | BBB |
Rapamycin Katarzyna Kotulska | Phase 3 | BBB |
NPC-12G Nobelpharma | Phase 3 | BB |
Carbamazepine GRIN Therapeutics, Inc. | Phase 3 | BB |
Ganaxolone Marinus Pharmaceuticals | Phase 3 | BB |
View all 23 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →